Mobius Therapeutics™ Granted New US Patent for Injected Ophthalmic Mitomycin-C

Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, has been issued US Patent  Injection Apparatus and Method of Use.

Read more →